Search

Your search keyword '"De Filippo P"' showing total 792 results
Start Over Author "De Filippo P"
792 results on '"De Filippo P"'

207. The subcutaneous ICD replacement in the clinical practice: preliminary observations from the multicentre RHYTHM DETECT

Author

Bianchi, V, primary, Viani, S, additional, De Filippo, P, additional, Dello Russo, A, additional, Checchi, L, additional, Biffi, M, additional, Caravati, F, additional, Giammaria, M, additional, Pisano’, E, additional, Papa, A, additional, Francia, P, additional, Bongiorni, M, additional, Valsecchi, S, additional, and D’onofrio, A, additional

Published
2022
Full Text
View/download PDF

208. Real-world survival of model-3501 subcutaneous implantable defibrillator lead

Author

Viani, S, primary, Segreti, L, additional, Ottaviano, L, additional, Biffi, M, additional, Nigro, G, additional, Ricciardi, G, additional, Francia, P, additional, D’onofrio, A, additional, Bisignani, G, additional, Dello Russo, A, additional, De Filippo, P, additional, Solimene, F, additional, Scalone, A, additional, Botto, G, additional, and Migliore, F, additional

Published
2022
Full Text
View/download PDF

214. Impact of Right Ventricular Pacing in Patients With TAVR Undergoing Permanent Pacemaker Implantation.

Author

Bruno, Francesco, Munoz Pousa, Isabel, Saia, Francesco, Vaira, Matteo Pio, Baldi, Enrico, Leone, Pier Pasquale, Cabanas-Grandio, Pilar, Corcione, Nicola, Spinoni, Enrico Guido, Annibali, Gianmarco, Russo, Caterina, Ziacchi, Matteo, Caruzzo, Carlo Alberto, Ferlini, Marco, Lanzillo, Giuseppe, De Filippo, Ovidio, Dusi, Veronica, Gallone, Guglielmo, Castagno, Davide, and Patti, Giuseppe

Abstract

Long-term right ventricular pacing (VP) has been related to negative left ventricular remodeling and heart failure (HF), but there is a lack of evidence regarding the prognostic impact on transcatheter aortic valve replacement (TAVR) patients. The aim of the PACE-TAVI registry is to evaluate the association of high percentage of VP with adverse outcomes in patients with pacemaker implantation after TAVR. PACE-TAVI is an international multicenter registry of all consecutive TAVR patients who underwent permanent pacemaker implantation for conduction disturbances in the first 30 days after the procedure. Patients were divided into 2 subgroups according to the percentage of VP (<40% vs ≥40%) at pacemaker interrogation. The primary endpoint was the composite of cardiovascular mortality or hospitalization for HF. A total of 377 patients were enrolled, 158 with VP <40% and 219 with VP ≥40%. After multivariable adjustment, VP ≥40% was associated with a higher incidence of the primary endpoint (HR: 2.76; 95% CI: 1.39-5.51; P = 0.004), first HF hospitalization (HR: 3.37; 95% CI: 1.50-7.54; P = 0.003), and cardiovascular death (HR: 3.77; 95% CI: 1.02-13.88; P = 0.04), while the incidence of all-cause death was not significantly different (HR: 2.17; 95% CI: 0.80-5.90; P = 0.13). Patients with VP ≥ 40% showed a higher New York Heart Association functional class both at 1 year (P = 0.009) and at last available follow-up (P = 0.04) and a nonsignificant reduction of left ventricular ejection fraction (P = 0.18) on 1-year echocardiography, while patients with VP <40% showed significant improvement (P = 0.009). In TAVR patients undergoing permanent pacemaker implantation, a high percentage of right VP at follow-up is associated with an increased risk for cardiovascular death and HF hospitalization. These findings suggest the opportunity to minimize right VP through dedicated algorithms in post-TAVR patients without complete atrioventricular block and to evaluate a more physiological VP modality in patients with persistent complete atrioventricular block. [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

215. La implicación de España en actividades científicas sobre ciencia abierta. Análisis de proyectos y publicaciones científicas.

Author

De Filippo, Daniela and Lascurain-Sánchez, María Luisa

Subjects
OPEN scholarship, OPEN innovation, CITIZEN science, SCIENTOMETRICS, RESEARCH & development projects, LEADERSHIP
Abstract

Copyright of Revista Española de Documentación Científica is the property of Consejo Superior de Investigaciones Cientificas and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

216. Grey zones on the use of new oral anticoagulants in atrial fibrillation. Expert opinion [Grey zones sull'uso dei nuovi anticoagulanti orali nella fibrillazione atriale. Opinioni degli esperti]

Author

Di Pasquale, G, Iacovoni, A, Filardi, P, Giustozzi, M, De Ponti, R, Falanga, A, Botto, G, De Filippo, P, Gavazzi, A, Sciatti, E, Senni, M, Porcu, M, Di Pasquale G, Iacovoni A, Filardi PP, Giustozzi M, De Ponti R, Falanga A, Botto GL, De Filippo P, Gavazzi A, Sciatti E, Senni M, Porcu M, Di Pasquale, G, Iacovoni, A, Filardi, P, Giustozzi, M, De Ponti, R, Falanga, A, Botto, G, De Filippo, P, Gavazzi, A, Sciatti, E, Senni, M, Porcu, M, Di Pasquale G, Iacovoni A, Filardi PP, Giustozzi M, De Ponti R, Falanga A, Botto GL, De Filippo P, Gavazzi A, Sciatti E, Senni M, and Porcu M

Abstract

Clinical guidelines, while representing an objective reference to perform appropriate treatment choices, contain grey zones, where recommendations are not supported by solid evidence. In a conference held in Bergamo in October 2018, an attempt was made to highlight some of the main grey zones in Cardiology and, through a comparison between experts, to draw shared conclusions that can illuminate our clinical practice. This manuscript contains the statements of the symposium concerning the controversies regarding new oral anticoagulants (NOACs) and atrial fibrillation (AF). The manuscript represents the organization of the meeting, with an initial review of current guidelines on this topic, followed by an expert presentation of pros (white) and cons (black) related to the identified "gaps of evidence". For every issue is then reported the response derived from the votes of the experts and the public, the discussion and, finally, the highlights, which are intended as practical "take home messages" to be used in everyday clinical practice. The first topic concerns the indication for anticoagulant therapy in patients with subclinical AF revealed by implanted devices. The second issue examines the opportunity to use NOACs in oncological patients with AF. The third gap evaluates the necessity of anticoagulating patients with AF and CHA2DS2-VASc 1 or CHA2DS2-VASc 2 if women. The last "gap in evidence" concerns the preference of triple or double therapy in patients with AF and acute coronary syndrome/coronary stenting. The work has also been implemented with evidences deriving from important randomized studies published after the date of the Conference.

Published
2020

217. Linking Visual and Kinesthetic Imagery in Lipreading Instruction.

Author

De Filippo, Carol Lee

Abstract

Four groups of 12 young adult deaf subjects evaluated 2 aspects of lipreading training: source of video feedback (self or trainer) and timing of feedback (during or after speech production). Results substantiate the beneficial effects of multisensory feedback by practicing lipreading of one's own speech production. (Author/JDD)

Published
1995

219. Use of Ambiguous Visual Stimuli to Demonstrate the Value of Acoustic Cues in Speech Perception.

Author

De Filippo, Carol Lee and Clark, Catherine

Abstract

This study evaluated English phrases and sentences in a minimal-pairs syllable-test format, to assess use of acoustic cues in audiovisual perception of speech by persons with severe or profound hearing loss. Of 48 items, 39 were visually confusable; 16 items identified as visually confusable were reliably identifiable when sound was added. (Author/DB)

Published
1993

220. Análisis de buenas prácticas editoriales en igualdad de género en España.

Author

Ángeles Coslado, María, De Filippo, Daniela, Ros, Germán, and Sanz-Casado, Elías

Subjects
EDITORIAL policies, GENDER inequality, SCIENCE publishing, ACQUISITION of manuscripts, PUBLISHING
Abstract

Copyright of Revista Española de Documentación Científica is the property of Consejo Superior de Investigaciones Cientificas and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

221. Predictive factors of diagnostic accuracy of CT-guided transthoracic fine-needle aspiration for solid noncalcified, subsolid and mixed pulmonary nodules

Author

De Filippo, Massimo, Saba, Luca, Concari, Giorgio, Nizzoli, Rita, Ferrari, Lilia, Tiseo, Marcello, Ardizzoni, Andrea, Sverzellati, Nicola, Paladini, Ilaria, Ganazzoli, Chiara, Sconfienza, Luca Maria, Carrafiello, Giampaolo, Brunese, Luca, Genovese, Eugenio Annibale, Ampollini, Luca, Carbognani, Paolo, Rusca, Michele, Zompatori, Maurizio, and Rossi, Cristina

Published
2013
Full Text
View/download PDF

225. Performance of transcatheter pacing system use in Relation to Patient Age

Author

Nicosia, A, primary, Iacopino, S, additional, Nigro, G, additional, Zucchelli, G, additional, Tomasi, L, additional, D'Agostino, C, additional, Ziacchi, M, additional, Piacenti, M, additional, De Filippo, P, additional, Sgarito, G, additional, Foti, R, additional, Campisi, G, additional, Pepi, P, additional, and Palmisano, P, additional

Published
2021
Full Text
View/download PDF

226. V-ATPase in glioma stem cells: a novel metabolic vulnerability

Author

Storaci, Alessandra Maria, Bertolini, Irene, Martelli, Cristina, De Turris, Giorgia, Mansour, Nadia, Crosti, Mariacristina, De Filippo, Maria Rosaria, Ottobrini, Luisa, Valenti, Luca, Polledri, Elisa, Fustinoni, Silvia, Caroli, Manuela, Fanizzi, Claudia, Bosari, Silvano, Ferrero, Stefano, Zadra, Giorgia, and Vaira, Valentina

Published
2025
Full Text
View/download PDF

234. Isospin aspects in nuclear reactions involving Ca beams at 25 MeV/nucleon

Author

Lombardo, I., Agodi, C., Alba, R., Amorini, F., Anzalone, A., Auditore, L., Berceanu, I., Cardella, G., Cavallaro, S., Chatterjee, M. B., De Filippo, E., Di Pietro, A., Figuera, P., Giuliani, G., Geraci, E., Grassi, L., Grzeszczuk, A., Han, J., La Guidara, E., Lanzalone, G., Le Neindre, N., Loria, D., Maiolino, C., Pagano, A., Papa, M., Pirrone, S., Politi, G., Pop, A., Porto, F., Rizzo, F., Russotto, P., Santonocito, D., Trifirò, A., Trimarchi, M., Verde, G., and Vigilante, M.

Published
2011
Full Text
View/download PDF

244. Grey zones on the use of new oral anticoagulants in atrial fibrillation. Expert opinion [Grey zones sull'uso dei nuovi anticoagulanti orali nella fibrillazione atriale. Opinioni degli esperti]

Author

Di Pasquale G, Iacovoni A, Filardi PP, Giustozzi M, De Ponti R, Falanga A, Botto GL, De Filippo P, Gavazzi A, Sciatti E, Senni M, Porcu M, Di Pasquale, G, Iacovoni, A, Filardi, P, Giustozzi, M, De Ponti, R, Falanga, A, Botto, G, De Filippo, P, Gavazzi, A, Sciatti, E, Senni, M, and Porcu, M

Subjects
New oral anticoagulant, CHA2DS2-VASc score, Atrial high-rate episode, Guideline, Triple therapy, Atrial fibrillation
Abstract

Clinical guidelines, while representing an objective reference to perform appropriate treatment choices, contain grey zones, where recommendations are not supported by solid evidence. In a conference held in Bergamo in October 2018, an attempt was made to highlight some of the main grey zones in Cardiology and, through a comparison between experts, to draw shared conclusions that can illuminate our clinical practice. This manuscript contains the statements of the symposium concerning the controversies regarding new oral anticoagulants (NOACs) and atrial fibrillation (AF). The manuscript represents the organization of the meeting, with an initial review of current guidelines on this topic, followed by an expert presentation of pros (white) and cons (black) related to the identified "gaps of evidence". For every issue is then reported the response derived from the votes of the experts and the public, the discussion and, finally, the highlights, which are intended as practical "take home messages" to be used in everyday clinical practice. The first topic concerns the indication for anticoagulant therapy in patients with subclinical AF revealed by implanted devices. The second issue examines the opportunity to use NOACs in oncological patients with AF. The third gap evaluates the necessity of anticoagulating patients with AF and CHA2DS2-VASc 1 or CHA2DS2-VASc 2 if women. The last "gap in evidence" concerns the preference of triple or double therapy in patients with AF and acute coronary syndrome/coronary stenting. The work has also been implemented with evidences deriving from important randomized studies published after the date of the Conference.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results